For years, the opioid epidemic has been one of the greatest public health crises in the United States. Overdose deaths, particularly from synthetic opioids like fentanyl, have claimed hundreds of thousands of lives and contributed significantly to a decline in the nation’s life expectancy. However, recent data from the Centers for Disease Control and Prevention (CDC) provides a glimmer of hope. According to their report, average life expectancy in the U.S. increased from 78.6 years in 2017 to 78.7 years in 2018. While the increase may seem small, it marks a reversal of a troubling downward trend, largely driven by a decline in overall drug overdose deaths.
This improvement, though modest, suggests progress in addressing the opioid crisis and points to the potential for even greater gains in public health if overdose deaths continue to decrease.
Understanding the Connection Between Life Expectancy and Opioid Deaths
Life expectancy is a critical measure of a population’s overall health. It represents the average number of years a newborn is expected to live, assuming current mortality rates persist throughout their lifetime. Over the last few decades, the United States has made significant advances in extending life expectancy through improvements in medicine, public health initiatives, and healthier lifestyles.
However, between 2014 and 2017, life expectancy in the U.S. declined for three consecutive years—the longest sustained decline since World War I and the influenza pandemic of 1918. Much of this decline was driven by drug overdose deaths, particularly among younger adults. Opioid overdoses have disproportionately affected people in their 20s, 30s, and 40s—age groups that typically have lower mortality rates. As a result, their deaths have an outsized effect on the national life expectancy.
In 2017, life expectancy fell to 78.6 years, down from a peak of 78.9 years in 2014. This decline was a stark reminder of how powerful the opioid epidemic had become in shaping the overall health trajectory of the nation.
A Decline in Drug Overdose Deaths
The CDC’s report highlights an encouraging trend: overall drug overdose deaths declined by more than 4% in 2018 compared to the year prior. This was the first time in decades that overdose deaths had declined, suggesting that prevention and treatment efforts may be beginning to make an impact.
While synthetic opioids such as fentanyl continued to drive increases in overdose deaths during 2018, heroin-related overdoses dropped. This reduction in heroin deaths helped offset the rise in fentanyl-related fatalities and contributed to the overall decline in drug overdose deaths.
Public health officials attribute the decrease to several factors, including:
- Expanded access to naloxone (Narcan): The life-saving medication that reverses opioid overdoses has become more widely available to first responders, community organizations, and even family members of those at risk.
- Increased awareness and education: Public health campaigns and community initiatives have helped reduce stigma and encouraged more people to seek treatment.
- Changes in prescribing practices: Efforts to limit the overprescription of opioid painkillers have reduced the number of individuals first exposed to opioids through legal prescriptions.
- Improved treatment access: More states have invested in expanding access to medication-assisted treatment (MAT), which uses medications like buprenorphine and methadone to help individuals manage opioid use disorder and reduce the risk of overdose.
Why Life Expectancy Matters
Even though life expectancy increased only by 0.1 years between 2017 and 2018, the improvement is meaningful because it represents a reversal of a worrying trend. For years, the United States was one of the few developed nations where life expectancy was falling, primarily due to preventable causes like drug overdoses and suicides.
If drug-related deaths continue to decline, experts believe life expectancy could continue to improve. Topias Lemetyinen, a managing epidemiologist at GlobalData, put it simply: “If this trend continues and drug-related deaths continue to decline, the U.S. could see further improvements in overall life expectancy in the coming years.”
Life expectancy serves as both a marker of progress and a call to action. Small increases show that policies and interventions can make a difference, but they also underscore the need for sustained investment in public health and addiction treatment.
Challenges That Remain
While the decline in overdose deaths in 2018 is promising, challenges remain. The opioid epidemic has evolved in ways that continue to make it difficult to combat:
- The rise of fentanyl: Synthetic opioids like fentanyl are far more potent than heroin or prescription opioids. Even tiny amounts can cause fatal overdoses, and fentanyl is increasingly being mixed into other drugs like cocaine and methamphetamine, often without users’ knowledge.
- Regional disparities: Not all areas of the U.S. have experienced declines in overdose deaths. Some regions, particularly in the Midwest and Northeast, continue to struggle with high rates of opioid-related fatalities.
- Access to treatment: Despite progress, many individuals with opioid use disorder still lack access to affordable, evidence-based treatment. Barriers include cost, lack of insurance coverage, stigma, and shortages of qualified providers.
- Co-occurring mental health disorders: Many individuals with substance use disorders also struggle with mental health conditions like depression, anxiety, or trauma. Without integrated treatment, the risk of relapse and overdose remains high.
Building on Progress
The data from 2018 shows that progress is possible, but it also highlights the importance of building on what is working. Several strategies could help sustain and accelerate the decline in overdose deaths and improve life expectancy further:
- Expand access to MAT: Research has consistently shown that medication-assisted treatment with buprenorphine or methadone reduces the risk of overdose and helps individuals maintain long-term recovery. Yet, MAT remains underutilized.
- Increase naloxone availability: Making naloxone available to more communities, including rural areas, can prevent overdose deaths in real-time.
- Reduce stigma: Encouraging people to view addiction as a chronic disease rather than a moral failing can increase the likelihood of individuals seeking treatment.
- Improve prevention efforts: Addressing root causes of substance misuse, such as chronic pain, trauma, and lack of economic opportunity, can help reduce the number of people who develop opioid use disorder in the first place.
- Support recovery services: Recovery is a lifelong process. Providing housing support, job training, and peer recovery programs can reduce the likelihood of relapse and overdose.
Looking Ahead
The increase in life expectancy from 2017 to 2018 may be small, but it represents an important step forward. After years of decline, largely fueled by opioid-related deaths, the nation has shown that progress is possible. However, the opioid epidemic continues to evolve, and vigilance is needed to ensure that gains are not reversed.
With sustained efforts in prevention, treatment, and recovery support, the U.S. could continue to see improvements in life expectancy and begin to turn the tide on one of the most devastating public health crises of our time.
